Global Circulating Tumor Cells (CTC) Market, By Technology (CTC Detection and Enrichment Methods, CTC Direct Detection Methods, CTC Analysis), Product (Kits and Reagents, Blood Collection Tubes, Devices or Systems), Specimen (Blood, Bone Marrow, Other Body Fluids) Application (Clinical/Liquid Biopsy, Research), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Circulating Tumor Cells (CTC) Market
The circulating tumor cells (CTC) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 26.12 billion by 2028 and will grow at a CAGR of 12.71% in the above mentioned forecast period.
Circulating tumor cells (CTC) are the type of cells which are generally found in vasculature or lymphatics through a tumor and through blood circulations, and are carried around the body. CTC test are to help the oncologist in checking whether the patient have metastatic breast, prostate or colorectal cancer.
The rise in the awareness about the application of CTC in cancer management is amongst the important factor expected to intensify the growth and demand of circulating tumor cells (CTC) market. In addition, the rise in preference of people in the developing economies for hospitals over other medical facilities due to affordability are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the increase in prevalence of multiple chromosome abnormality syndromes and presence of sophisticated healthcare infrastructure are also likely to enhance the growth of the market. Furthermore, the high prevalence for preventive medicine and rapid development in the cluster chip technology also one of the significant factors expected to fuel the growth of the circulating tumor cells (CTC) market.
The rapid advancement in technology, development in the biomedical imaging and bioengineering processes and high demand for efficient diagnostic and screening tests are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the lack of awareness about the advanced CTC technologies and high cost of the CTC are expected to curb the growth of the circulating tumor cells (CTC) market, whereas the rise in the prevalence for point of care testing can challenge the growth of the circulating tumor cells (CTC) market.
This circulating tumor cells (CTC) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the circulating tumor cells (CTC) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Circulating Tumor Cells (CTC) Market Scope and Market Size
The circulating tumor cells (CTC) market is segmented on the basis of technology, product, specimen, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on technology, the circulating tumor cells (CTC) market is segmented into CTC detection and enrichment methods, CTC direct detection methods and CTC analysis. CTC detection and enrichment methods have further been segmented into immunocapture (label-based), size-based separation (label-free), density-based separation (label-free) and combined methods (label-free). Immunocapture (label-based) is further sub-segmented into positive selection and negative selection. Size-based separation (label-free) is further sub-segmented into membrane-basedand microfluidic-based. CTC direct detection methods have further been segmented into SERS, microscopy and others.
- On the basis of product, the circulating tumor cells (CTC) market is segmented into kits and reagents, blood collection tubes and devices or systems.
- Based on specimen, the circulating tumor cells (CTC) market is segmented into blood, bone marrow and other body fluids.
- The application segment of circulating tumor cells (CTC) market is segmented into clinical/liquid biopsy and research. Clinical/liquid biopsy has further been segmented into risk assessment and screening and monitoring. Research has further been segmented into cancer stem cell and tumorigenesis research and drug/therapy development
- On the basis of end user, the circulating tumor cells (CTC) market is segmented into hospitals, clinics, research and academic institutes, diagnostic centers and others.
Circulating Tumor Cells (CTC) Market Country Level Analysis
The circulating tumor cells (CTC) market is analyzed and market size insights and trends are provided by country, technology, product, specimen, application and end user as referenced above.
The countries covered in the circulating tumor cells (CTC) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the circulating tumor cells (CTC) market owing to the well-established healthcare infrastructure and high addition of advanced diagnostic technologies. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high unmet diagnostic needs and rapid rise in the patient awareness regarding early detection of cancer and risk assessment.
The country section of the circulating tumor cells (CTC) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The circulating tumor cells (CTC) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for circulating tumor cells (CTC) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the circulating tumor cells (CTC) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Circulating Tumor Cells (CTC) Market Share Analysis
The circulating tumor cells (CTC) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to circulating tumor cells (CTC) market.
The major players covered in the circulating tumor cells (CTC) market report are Thermo Fisher Scientific Inc., GENERAL ELECTRIC, F. Hoffmann-La Roche Ltd., STEMCELL Technologies Inc., SRI INTERNATIONAL, QIAGEN, NanoString, Miltenyi Biotec, Menarini Silicon Biosystems., Ikonisys, Inc., Greiner Bio One International GmbH, Precision Medicine Group, LLC, Creatv MicroTech, Inc., Aviva Systems Biology Corporation, Advanced Cell Diagnostics, Inc., iCellate AB, CytoLumina, Bio-Techne, Biocept, Inc., and Rarecells, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-